Table 1 Demographic data and tumor characteristics
Parameter | n = 73 |
|---|---|
Gender (M/F) | |
 Male | 63 |
 Female | 10 |
Age (year)a | 54.9 ± 11.6 (25–79) |
Etiology | |
 HBV | 55 |
 HCV | 4 |
 Others | 14 |
Tumor type | |
 Naïve | 19 |
 Recurrent | 54 |
Surgery history of liver | |
 Yes | 34 |
 No | 37 |
Liver cirrhosis | |
 Yes | 51 |
 No | 22 |
Antiviral treatment | |
 Yes | 42 |
 No | 31 |
ECOG performance status (0/1) | |
 0 | 71 |
 1 | 2 |
Child-Pugh | |
 A | 67 |
 B | 6 |
Tumor stage of primary HCC | |
 BCLC A | 61 |
 BCLC B | 12 |
Laboratory data # | |
 AFP (μg/L) | 1021.4 ± 2216.2 (1.85–8034.17) |
 PLT (× 109/L) | 174.1 ± 71.4 (69–345) |
 PT (s) | 12.6 ± 1.1 (10.5–17.1) |
 ALB (g/L) | 40.4 ± 4.8 (27–49.7) |
 ALT (IU/L) | 29.9 ± 16.9 (7–84) |
 TB (mol/L) | 13.6 ± 5.7 (5.4–30.8) |
Tumor number | |
 Single | 38 |
 Multiple | 33 |
Location | |
 Paracaval portion | 36 |
 Caudate process | 7 |
 Spiegel’s lobe | 30 |
Tumor size (cm) | |
 ≤ 2 cm | 32 |
 > 2 cm | 41 |
Treatment strategy | |
 RFA | 33 |
 EA | 23 |
 RFA-EA | 17 |
Ablative margin | |
 < 5 mm | 66 |
 ≥ 5 mm | 7 |